Strategies for testing long-term transcutaneous amperometric glucose sensors

Diabetes Technology and Therapeutics

Volumn 7, Issue 6, 2005, Pages 927-936

  Long, Nathan ^a   Yu, Bazhang ^a   Moussy, Yvonne ^a   Moussy, Francis ^a  

^a University of South Florida   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPEROMETRIC BIOSENSOR; ANIMAL EXPERIMENT; ANIMAL WELFARE; ARTICLE; CONTROLLED STUDY; DEVICE; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; ELECTROCHEMICAL ANALYSIS; IMPLANT; IN VIVO STUDY; INFECTION CONTROL; MALE; NONHUMAN; PERFORMANCE; PRIORITY JOURNAL; RAT; TECHNIQUE; TRANSCUTANEOUS AMPEROMETRIC GLUCOSE SENSOR;

ANIMALS; BIOSENSING TECHNIQUES; BLOOD GLUCOSE; DIABETES MELLITUS; MALE; MONITORING, PHYSIOLOGIC; RATS; RATS, SPRAGUE-DAWLEY;

EID: 31144479158     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2005.7.927     Document Type: Article

References (35)

1. Krinsley JS: Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 2004;79:992-1000.
2. Grey NJ, Perdrizet GA: Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. Endocr Pract 2004;10(Suppl 2):46-52.
3. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
4. UKPDS Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853.
5. American Diabetes Association: Implications of the Diabetes Control and Complications Trial. Diabetes Care 2003;26(Suppl):S25-S32.
6. McCarren M: American Diabetes Association. Resource guide 2005. Class action: type 2 pills update. Diabetes Forecast 2005;58:RG6-RG9.
7. Oiknine R, Bernbaum M, Mooradian AD: A critical appraisal of the role of insulin analogues in the management of diabetes mellitus. Drugs 2005;65:325-340.
8. Guerci B, Drouin P, Grange V, Bougneres P, Fontaine P, Kerlan V, Passa P, Thivolet Ch, Vialettes B, Charbonnel B; ASIA Group: Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab 2003;29:587-594.
9. Schwedes U, Siebolds M, Mertes G; SMBG Study Group: Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin-treated type 2 diabetic patients. Diabetes Care 2002;25:1928-1932.
10. Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care 1998;21:296-309.
11. WHO 2004 Diabetes Action Now: An Initiative of the World Health Organization and the International Diabetes Federation. Geneva: World Health Organization, 2004.
12. Chia CW, Saudek CD: Glucose sensors: toward closed loop insulin delivery. Endocrinol Metab Clin North Am 2004;33:175-195, xi.
13. Clark LC Jr, Lyons C: Electrode systems for continuous monitoring in cardiovascular surgery. Ann N Y Acad Sci 1962;102:29-15.
14. Magner E: Trends in electrochemical biosensors. Analyst 1998;123:1967-1970.
15. Wilson GS, Gifford R: Biosensors for real-time in vivo measurements. Biosens Bioelectron 2005;20:2388-2403. Epub 2005 Jan 15.
16. Kissinger PT: Biosensors - a perspective. Biosens Bioelectron 2005;20:2512-2516.
17. Gilligan BC, Shults M, Rhodes RK, Jacobs PG, Brauker JH, Pintar TJ, Updike SJ: Feasibility of continuous long-term glucose monitoring from a subcutaneous glucose sensor in humans. Diabetes Technol Ther 2004;6:378-386.
18. Kyrolainen M, Rigsby P, Eddy S, Vadgama P: Bio-/ haemocompatibility: implications and outcomes for sensors? Acta Anaesthesiol Scand Suppl 1995;104:55-60.
19. Kerner W, Kiwit M, Linke B, Keck FS, Zier H, Pfeiffer EF: The function of a hydrogen peroxide-detecting electroenzymatic glucose electrode is markedly impaired in human sub-cutaneous tissue and plasma. Biosens Bioelectron 1993;8:473-482.
20. Wisniewski N, Moussy F, Reichert WM: Characterization of implantable biosensor membrane biofouling. Fresenius J Anal Chem 2000;366:611-621.
21. Yu B, Moussy Y, Moussy F: Coil-type implantable glucose biosensor with excess enzyme loading. Front Biosci 2005;10:512-20. Print 2005 Jan 1.
22. Gerritsen M, Kros A, Lutterman JA, Nolte RJ, Jansen JA: A percutaneous device as model to study the in vivo performance of implantable amperometric glucose sensors. J Mater Sci Mater Med 2001;12:129-134.
23. Rebrin K, Fischer U, Hahn von Dorsche H, von Woetke T, Abel P, Brunstein E: Subcutaneous glucose monitoring by means of electrochemical sensors: fiction or reality? J Biomed Eng 1992;14:33-40.
24. Yu B, Moussy Y, Moussy F: Lifetime improvement of glucose biosensor by epoxy-enhanced PVC membrane. Electroanalysis 2005;17:1771-1779.
25. Updike SJ, Shults MC, R.K. Rhodes RK, Gilligan BJ, Luebow JO, von Heimburg D: Enzymatic glucose sensors. Improved long-term performance in vitro and in vivo. ASAIO J 1994;40:157-163.
26. Moussy F, Reichert WM: Biomaterials community examines biosensor biocompatibility. Diabetes Technol Ther 2000;2:473.
27. Norton LW, Tegnell E, Toporek SS, Reichert WM: In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings. Biomaterials 2005;26:3285-3297.
28. Hickey T, Kreutzer DL, Burgess DJ, Moussy F: In vivo evaluation of a dexamethasone/PLGA microsphere system designed to suppress the inflammatory tissue response to implantable medical devices. J Biomed Mater Res 2002;61:180-187.
29. Ward WK, Quinn MJ, Wood MD, Tiekotter KL, Pidikiti S, Gallagher JA: Vascularizing the tissue surrounding a model biosensor: how localized is the effect of a subcutaneous infusion of vascular endothelial growth factor (VEGF)? Biosens Bioelectron 2003;19:155-163.
30. Santos RF, Mondon CE, Reaven GM, Azhar S: Effects of exercise training on the relationship between insulin binding and insulin-stimulated tyrosine kinase activity in rat skeletal muscle. Metabolism 1989;38:376-386.
31. Ward WK, Jansen LB, Anderson E, Reach G, Klein JC, Wilson GS: A new amperometric glucose microsensor: in vitro and short-term in vivo evaluation. Biosens Bioelectron 2002;17:181-189.
32. Thome-Duret V, Aussedat B, Reach G, Gangnerau MN, Lemonnier F, Klein JC, Zhang Y, Hu Y, Wilson GS: Continuous glucose monitoring in the free-moving rat. Metabolism 1998;47:799-803.
33. Forster J, Morris AS, Shearer JD, Mastrofrancesco B, Inman KC, Lawler RG, Bowen W, Caldwell MD: Glucose uptake and flux through phosphofructokinase in wounded rat skeletal muscle. Am J Physiol 1989;256:E788-E797.
34. Lutgers HL, Hullegie LM, Hoogenberg K, Sluiter WJ, Dullaart RPF, Wientjes KJ, Schoonen AJM: Microdialysis measurement of glucose in subcutaneous adipose tissue up to three weeks in Type 1 diabetic patients. Neth J Med 2000;57:7-12.
35. Gerritsen M, Paquay YG, Jansen JA: Evaluation of the tissue reaction to a percutaneous access device using titanium fibre mesh anchorage in goats. J Mater Sci Mater Med 1998;9:523-528.